Deep learning-derived retinal biomarker associated with diabetes-related amputation in type 2 diabetes - Summary - MDSpire

Deep learning-derived retinal biomarker associated with diabetes-related amputation in type 2 diabetes

  • By

  • Junseok Park

  • Jung Soo Yoon

  • Sahil Thakur

  • Dongjin Nam

  • Sunjin Hwang

  • July 1, 2026

  • 0 min

Share

Objective:

To assess the independent association between a deep learning-derived retinal biomarker and DF-related amputation in patients with type 2 diabetes.

Approach:
  • Study Design: A retrospective observational study including 392 individuals with type 2 diabetes, split into training (70%) and validation (30%) sets.
  • Data Collection: Participants underwent fundus photography and had baseline HbA1c measurements; demographic and clinical variables were reviewed.
  • Model Evaluation: Model performance was assessed using AUC, cNRI, and IDI, with prespecified sensitivity and specificity thresholds.
Key Findings:
  • The retinal biomarker showed an incremental association with DF-related amputation (AUC 0.146, 95% CI: 0.046-0.249; cNRI 0.629, 95% CI: 0.184-1.027; IDI 0.062, 95% CI: 0.012-0.110).
  • The full model achieved an AUC of 0.791.
  • At a 27% amputation prevalence, sensitivity was 87.5% and specificity was 90.4%.
Interpretation:

A DL-derived retinal biomarker is associated with DF-related amputation risk beyond conventional diabetes variables.

Limitations:
  • The study is retrospective and conducted at a single center.
  • The sample size may limit generalizability.
Conclusion:

Original Source(s)

Related Content